hydroxyproline has been researched along with Cystadenocarcinoma in 1 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waalkes, TP | 1 |
| Rosenshein, NB | 1 |
| Shaper, JH | 1 |
| Ettinger, DS | 1 |
| Woo, KB | 1 |
| Paone, JF | 1 |
| Gehrke, CW | 1 |
1 other study available for hydroxyproline and Cystadenocarcinoma
| Article | Year |
|---|---|
A feasibility study in the development of biological markers for ovarian cancer.
Topics: Aminoisobutyric Acids; Body Fluids; Carcinoembryonic Antigen; Chorionic Gonadotropin; Cystadenocarci | 1982 |